Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document C2006/159/07

    Prior notification of a concentration (Case COMP/M.4308 — BC Partners/Médica) — Candidate case for simplified procedure Text with EEA relevance

    OB C 159, 8.7.2006, p. 76–76 (ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, NL, PL, PT, SK, SL, FI, SV)

    8.7.2006   

    EN

    Official Journal of the European Union

    C 159/76


    Prior notification of a concentration

    (Case COMP/M.4308 — BC Partners/Médica)

    Candidate case for simplified procedure

    (2006/C 159/07)

    (Text with EEA relevance)

    1.

    On 3 July 2006, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings BC European Capital VII, BC European Capital VII Top-Up and BC European Capital VIII (together ‘BC Partners’, UK) belonging to BC Partners Holdings Limited acquire within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Médica SA (‘Médica’, France) by way of purchase of shares.

    2.

    The business activities of the undertakings concerned are:

    for undertaking BC Partners: investment funds;

    for undertaking Médica: care homes for elderly people, rehabilitation centre and mental health centre.

    3.

    On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

    4.

    The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

    Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (fax No (32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4308 — BC Partners/Médica, to the following address:

    European Commission

    Directorate-General for Competition

    Merger Registry

    J-70

    B-1049 Bruxelles/Brussel


    (1)  OJ L 24, 29.1.2004, p. 1.

    (2)  OJ C 56, 5.3.2005, p. 32.


    Top